Medulloblastomics revisited: biological and clinical insights from thousands of patients

被引:156
作者
Hovestadt, Volker [1 ,2 ,3 ,4 ]
Ayrault, Olivier [5 ,6 ]
Swartling, Fredrik J. [7 ]
Robinson, Giles W. [8 ]
Pfister, Stefan M. [9 ,10 ,11 ,12 ]
Northcott, Paul A. [13 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Broad Inst Harvard & MIT, Cambridge, MA USA
[5] PSL Res Univ, CNRS, Inst Curie, INSERM,UMR, Orsay, France
[6] Univ Paris Saclay, Univ Paris Sud, INSERM, U1021,CNRS,UMR 3347, Orsay, France
[7] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden
[8] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[9] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany
[10] German Canc Res Ctr, Div Paediat Neurooncol, Heidelberg, Germany
[11] German Canc Consortium DKTK, Heidelberg, Germany
[12] Heidelberg Univ Hosp, Dept Paediat Haematol & Oncol, Heidelberg, Germany
[13] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
CENTRAL-NERVOUS-SYSTEM; MIR-17-SIMILAR-TO-92 CLUSTER FAMILY; TERT PROMOTER MUTATIONS; ACUTE MYELOID-LEUKEMIA; C-MYC ONCOGENE; CHILDHOOD MEDULLOBLASTOMA; MOLECULAR SUBGROUPS; MOUSE MODEL; STEM-CELL; ENHANCER HIJACKING;
D O I
10.1038/s41568-019-0223-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medulloblastoma, a malignant brain tumour primarily diagnosed during childhood, has recently been the focus of intensive molecular profiling efforts, profoundly advancing our understanding of biologically and clinically heterogeneous disease subgroups. Genomic, epigenomic, transcriptomic and proteomic landscapes have now been mapped for an unprecedented number of bulk samples from patients with medulloblastoma and, more recently, for single medulloblastoma cells. These efforts have provided pivotal new insights into the diverse molecular mechanisms presumed to drive tumour initiation, maintenance and recurrence across individual subgroups and subtypes. Translational opportunities stemming from this knowledge are continuing to evolve, providing a framework for improved diagnostic and therapeutic interventions. In this Review, we summarize recent advances derived from this continued molecular characterization of medulloblastoma and contextualize this progress towards the deployment of more effective, molecularly informed treatments for affected patients.
引用
收藏
页码:42 / 56
页数:15
相关论文
共 146 条
  • [61] TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours
    Lindsey, Janet C.
    Schwalbe, Ed C.
    Potluri, Sandeep
    Bailey, Simon
    Williamson, Daniel
    Clifford, Steven C.
    [J]. ACTA NEUROPATHOLOGICA, 2014, 127 (02) : 307 - 309
  • [62] LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma
    Liu, Zhongyuan
    Zhang, Hui
    [J]. ONCOTARGET, 2017, 8 (38) : 64273 - 64282
  • [63] The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
    Louis, David N.
    Perry, Arie
    Reifenberger, Guido
    von Deimling, Andreas
    Figarella-Branger, Dominique
    Cavenee, Webster K.
    Ohgaki, Hiroko
    Wiestler, Otmar D.
    Kleihues, Paul
    Ellison, David W.
    [J]. ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 803 - 820
  • [64] Population-based epidemiological study of primary intracranial tumors in childhood
    Makino, Keishi
    Nakamura, Hideo
    Yano, Shigetoshi
    Kuratsu, Jun-ichi
    [J]. CHILDS NERVOUS SYSTEM, 2010, 26 (08) : 1029 - 1034
  • [65] CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma
    Martin-Garcia, David
    Navarro, Alba
    Valdes-Mas, Rafael
    Clot, Guillem
    Gutierrez-Abril, Jesus
    Prieto, Miriam
    Ribera-Cortada, Inmaculada
    Woroniecka, Renata
    Rymkiewicz, Grzegorz
    Bens, Susanne
    de Leval, Laurence
    Rosenwald, Andreas
    Ferry, Judith A.
    Hsi, Eric D.
    Fu, Kai
    Delabie, Jan
    Weisenburger, Dennis
    de Jong, Daphne
    Climent, Fina
    O'Connor, Sheila J.
    Swerdlow, Steven H.
    Torrents, David
    Beltran, Sergi
    Espinet, Blanca
    Gonzalez-Farre, Blanca
    Veloza, Luis
    Costa, Dolors
    Matutes, Estella
    Siebert, Reiner
    Ott, German
    Quintanilla-Martinez, Leticia
    Jaffe, Elaine S.
    Lopez-Otin, Carlos
    Salaverria, Itziar
    Puente, Xose S.
    Campo, Elias
    Bea, Silvia
    [J]. BLOOD, 2019, 133 (09) : 940 - 951
  • [66] Genetic Grouping of Medulloblastomas by Representative Markers in Pathologic Diagnosis
    Min, Hye Sook
    Lee, Ji Yeoun
    Kim, Seung-Ki
    Park, Sung-Hye
    [J]. TRANSLATIONAL ONCOLOGY, 2013, 6 (03) : 265 - 272
  • [67] From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
    Moeroey, Tarik
    Vassen, Lothar
    Wilkes, Brian
    Khandanpour, Cyrus
    [J]. BLOOD, 2015, 126 (24) : 2561 - 2569
  • [68] An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
    Morabito, Morgane
    Larcher, Magalie
    Cavalli, Florence M. G.
    Foray, Chloe
    Forget, Antoine
    Mirabal-Ortega, Liliana
    Andrianteranagna, Mamy
    Druillennec, Sabine
    Garancher, Alexandra
    Masliah-Planchon, Julien
    Leboucher, Sophie
    Debalkew, Abel
    Raso, Alessandro
    Delattre, Olivier
    Puget, Stephanie
    Doz, Francois
    Taylor, Michael D.
    Ayrault, Olivier
    Bourdeaut, Franck
    Eychene, Alain
    Pouponnot, Celio
    [J]. EMBO MOLECULAR MEDICINE, 2019, 11 (08)
  • [69] Spatial heterogeneity in medulloblastoma
    Morrissy, A. Sorana
    Cavalli, Florence M. G.
    Remke, Marc
    Ramaswamy, Vijay
    Shih, David J. H.
    Holgado, Borja L.
    Farooq, Hamza
    Donovan, Laura K.
    Garzia, Livia
    Agnihotri, Sameer
    Kiehna, Erin N.
    Mercier, Eloi
    Mayoh, Chelsea
    Papillon-Cavanagh, Simon
    Nikbakht, Hamid
    Gayden, Tenzin
    Torchia, Jonathon
    Picard, Daniel
    Merino, Diana M.
    Vladoiu, Maria
    Luu, Betty
    Wu, Xiaochong
    Daniels, Craig
    Horswell, Stuart
    Thompson, Yuan Yao
    Hovestadt, Volker
    Northcott, Paul A.
    Jones, David T. W.
    Peacock, John
    Wang, Xin
    Mack, Stephen C.
    Reimand, Juri
    Albrecht, Steffen
    Fontebasso, Adam M.
    Thiessen, Nina
    Li, Yisu
    Schein, Jacqueline E.
    Lee, Darlene
    Carlsen, Rebecca
    Mayo, Michael
    Tse, Kane
    Tam, Angela
    Dhalla, Noreen
    Ally, Adrian
    Chuah, Eric
    Cheng, Young
    Plettner, Patrick
    Li, Haiyan I.
    Corbett, Richard D.
    Wong, Tina
    [J]. NATURE GENETICS, 2017, 49 (05) : 780 - +
  • [70] Divergent clonal selection dominates medulloblastoma at recurrence
    Morrissy, A. Sorana
    Garzia, Livia
    Shih, David J. H.
    Zuyderduyn, Scott
    Huang, Xi
    Skowron, Patryk
    Remke, Marc
    Cavalli, Florence M. G.
    Ramaswamy, Vijay
    Lindsay, Patricia E.
    Jelveh, Salomeh
    Donovan, Laura K.
    Wang, Xin
    Luu, Betty
    Zayne, Kory
    Li, Yisu
    Mayoh, Chelsea
    Thiessen, Nina
    Mercier, Eloi
    Mungall, Karen L.
    Ma, Yusanne
    Tse, Kane
    Zeng, Thomas
    Shumansky, Karey
    Roth, Andrew J. L.
    Shah, Sohrab
    Farooq, Hamza
    Kijima, Noriyuki
    Holgado, Borja L.
    Lee, John J. Y.
    Matan-Lithwick, Stuart
    Liu, Jessica
    Mack, Stephen C.
    Manno, Alex
    Michealraj, K. A.
    Nor, Carolina
    Peacock, John
    Qin, Lei
    Reimand, Juri
    Rolider, Adi
    Thompson, Yuan Y.
    Wu, Xiaochong
    Pugh, Trevor
    Ally, Adrian
    Bilenky, Mikhail
    Butterfield, Yaron S. N.
    Carlsen, Rebecca
    Cheng, Young
    Chuah, Eric
    Corbett, Richard D.
    [J]. NATURE, 2016, 529 (7586) : 351 - +